FDA Releases Guidance on Minimal Manipulation and Homologous Use of Human Cells, Tissues, and Products

Summary

The Food and Drug Administration (FDA) has published a guidance document outlining its regulatory thinking on minimal manipulation and homologous use of human cells, tissues, and products, aiming to clarify definitions and enforcement discretion for industry stakeholders.